Ranked #1

Hoth Therapeutics, Inc. (NASDAQ: HOTH) Dermatological therapeutics pipeline targeting multi-billion dollar opportunities (+ near-term catalysts)
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Dermatological therapeutics pipeline targeting multi-billion dollar opportunities (+ near-term catalysts)
Hoth Therapeutics, Inc. (NASDAQ: HOTH) will be a featured presenter at Wall Street Reporter’s Next Super Stock Live! onl... Read more
4 Sep 2019
•
24mins
Ranked #2

Phunware, Inc. (NASDAQ: PHUN): Next $100 Billion Company of Decentralized Computing era?
Phunware, Inc. (NASDAQ: PHUN): Next $100 Billion Company of Decentralized Computing era?
Phunware, Inc. (NASDAQ: PHUN) interview with CEO Alan Knitowski discussing the company's leadership position in mobile a... Read more
21 Jul 2019
•
44mins
Ranked #3

CytoDyn Inc. (OTC: CYDY) HIV therapy nearing FDA approval + drug pipeline with blockbuster potential
CytoDyn Inc. (OTC: CYDY) HIV therapy nearing FDA approval + drug pipeline with blockbuster potential
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, providing an update on the company’s drug developmen... Read more
18 Jul 2019
•
24mins
Ranked #4

American Premium Water Corp (OTC: HIPH) Building CBD-infused consumer brand portfolio
American Premium Water Corp (OTC: HIPH) Building CBD-infused consumer brand portfolio
American Premium Water Corp (OTC: HIPH) interview with CEO, Ryan Fishoff discussing the company’s growth strategy in bui... Read more
30 Apr 2019
•
29mins
Ranked #5

The Yield Growth Corp. (CSE: BOSS) Building brands “At the intersection of cannabis & wellness”
The Yield Growth Corp. (CSE: BOSS) Building brands “At the intersection of cannabis & wellness”
The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Interview with CEO, Penny Green.In this follow-up to our December 20, 20... Read more
5 Apr 2019
•
33mins
Ranked #6

CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019
CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody ther... Read more
11 Jan 2019
•
28mins
Ranked #7

Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams
Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams
Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. Andy explains what has been... Read more
27 Dec 2018
•
27mins
Ranked #8

Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products
Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products
We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods m... Read more
14 Dec 2018
•
24mins
Ranked #9

CellCube Energy Systems (OTC: CECBF) “$100 Million Sales Pipeline 2019”
CellCube Energy Systems (OTC: CECBF) “$100 Million Sales Pipeline 2019”
CellCube Energy Storage Systems Inc. (CSE: CUBE) (OTC: CECBF) “$100 Million Sales Pipeline 2019” Interview with CEO Mike... Read more
22 Oct 2018
•
33mins
Ranked #10

NexTech AR Solutions (OTC: NEXCF)”V-Commerce” Aims at Transforming $3.7 Trillion Retail Sector
NexTech AR Solutions (OTC: NEXCF)”V-Commerce” Aims at Transforming $3.7 Trillion Retail Sector
NEXT SUPER STOCK conference presenter NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) follow-up CEO Interview with Evan Ga... Read more
23 Jan 2020
•
21mins